Updated Vaccine Information Statement for Rotavirus Vaccine
December 17, 2010 -- The Bureau of Immunization wishes to announce the availability of an updated (interim) rotavirus Vaccine Information Statement (VIS) that was posted on December 7, 2010. (Updated Rotavirus VIS)
Updated Recommendations for the Use of Pneumococcal Conjugate and Polysaccharide Vaccines
December 16, 2010 -- The Bureau of Immunization wishes to call to your attention the following article in the. On December 10, 2010, Prevention of Pneumococcal Disease Among Infants and Children --- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine was published... (Use of Pneumococcal)
Training Resource (with CE and CME)
"Real Talk About Influenza Vaccine — Be Informed and Be Prepared"
December 16, 2010 -- The Centers for Disease Control and Prevention's (CDC) Immunization Safety Office is proud to offer a free continuing education (CME and CE) activity titled Real Talk About Influenza Vaccine — Be Informed and Be Prepared... (Training Resource)
Vaccines for Children Diphtheria, Tetanus, and Pertussis Resolution No. 10/10-2
November 30, 2010 -- The Bureau of Immunization is pleased to announce the release of Vaccines for Children (VFC) Program Resolution No. 10/10-2, Vaccines to Prevent Diphtheria, Tetanus and Pertussis. Resolution 6/08-3 is repealed and replaced by this new resolution that incorporates new recommendations regarding the interval between Tdap and last dose of Td for children aged 11 through 18 years of age and updates recommendations for certain children between 7 and 10 years of age. Resolution No. 10/10-2 is adopted and effective on October 27, 2010. The purpose of this resolution is to revise the previous resolution and streamline the recommendation through the use of links to published documents.
The VFC Program resolutions passed by the Advisory Committee on Immunization Practices (ACIP) form the basis for VFC Program policies on vaccine availability and usage. The VFC Program vaccine must be administered according to the guidelines outlined by the ACIP in the VFC Programs resolutions.
This document can be found on the Centers for Disease Control and Prevention (CDC) website at: www.cdc.gov/vaccines/programs/vfc/acip-vfc-resolutions.htm.
National Influenza Vaccination Week
November 19, 2010 -- National Influenza Vaccination Week (NIVW) is a nationwide effort to remind everyone of the importance of receiving the influenza vaccine, even when received after the start of the typical flu season.
Training Opportunity
Making the CASE for Vaccine Safety: A New Model for Communicating with Parents
November 18, 2010 -- The Bureau is pleased to share this training opportunity with our immunization partners.
Current Issues in Immunization
November 10, 2010 -- The Bureau of Immunization is pleased to promote the Current Issues in Immunization NetConference Series as presented by the Centers for Disease Control and Prevention (CDC). (Immunization Training Opportunity)
National Vaccine Recovery Program for H1N1 Influenza Vaccines Ends December 1, 2010
November 3, 2010 -- The Bureau of Immunization is reminding all novel H1N1 influenza and Vaccines for Children (VFC) Program providers who participated in the mass vaccination campaign for novel H1N1 influenza
Training Opportunity: Pertussis
September 27, 2010 -- The Bureau is pleased to announce an opportunity to take part in a web-based training program, Pertussis 2010—Response to an Epidemic. (Pertussis Training)
Information on Rotarix® Vaccine
September 27, 2010 -- The Bureau of Immunization wishes to bring to your attention the following information concerning prescribing information and patient labeling for Rotarix® vaccine, manufactured by GlaxoSmithKline. (Rotarix Vaccine)
Immunization Safety Update: Tetanus-Diphtheria-Pertussis-Containing Vaccines
September 22, 2010 -- This immunization update is a review of the administration/documentation of tetanus-diphtheria-pertussis-containing vaccines (Tdap/DTaP) in accordance with the Recommendations of the Advisory Committee on Immunization Practices (ACIP). (Immunization Safety Update)
Advisory Committee on Immunization Practices (ACIP) Recommendations for Use of CSL Influenza Vaccine
September 15, 2010 -- The Bureau of Immunization is pleased to share the following statement by the Centers for Disease Control and Prevention (CDC) regarding the Advisory Committee on Immunization Practices (ACIP) Recommendations for Use of CSL influenza vaccine during the 2010-2011 influenza season.
Update: Phase 2: National Vaccine Recovery Program for H1N1 Influenza Vaccines
September 2 , 2010 -- The Bureau of Immunization is pleased to provide this updated information on the National Vaccine Recovery Program for 2009 H1N1 influenza vaccines.
Update: National Vaccine Recovery Program for 2009 H1N1 Influenza Vaccines
August 27, 2010 -- The Bureau of Immunization wishes to remind all novel H1N1 influenza immunization providers participating in the National Vaccine Recovery Program of the following information.
2010-2011 Influenza Vaccine Update
August 20, 2010 -- The Bureau of Immunization is forwarding the following update regarding projections for the 2010-2011 influenza vaccine supply and labeling of latex-containing syringe tip caps.
Reminder of Procedure
National Vaccine Recovery Program for 2009 H1N1 Influenza Vaccines
August 18, 2010 -- The Bureau of Immunization wishes to remind all novel H1N1 influenza immunization providers participating in the National Vaccine Recovery Program of the following information.
Sanofi Pasteur Influenza A (H1N1) 2009 Monovalent Vaccine in Multi-dose Vials—Shortened Shelf Life
August 12, 2010 -- The Bureau of Immunization is pleased to share the information in the Centers for Disease Control and Prevention (CDC) Health Alert Network (HAN) service message concerning the shortening of shelf life for Sanofi Pasteur Influenza A (H1N1) 2009 Monovalent Vaccine in multi-dose vials.
2010-2011 Seasonal Influenza Interim Vaccine Information Statements
August 11, 2010 -- The Bureau of Immunization wishes to announce the availability of the 2010 Interim Influenza Vaccine Information Statements (VIS).
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010
August 9, 2010 -- The Centers for Disease Control and Prevention (CDC) published Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 on August 6, 2010.
Update: National Vaccine Recovery Program for H1N1 Influenza Vaccines
July 26, 2010 -- The Bureau of Immunization is pleased to provide this updated information on the National Vaccine Recovery Program for novel H1N1 influenza vaccines.
National Immunization Awareness Month
July 21, 2010 -- The Bureau of Immunization joins the Centers for Disease Control and Prevention (CDC) in recognizing August as National Immunization Awareness Month (NIAM).
Deadline for 2009 H1N1 Influenza Vaccine Orders
July 20, 2010 -- The Bureau of Immunization, in collaboration with the Centers for Disease Control and Prevention (CDC), is announcing the deadline for the final ordering and distribution of 2009 novel H1N1 influenza vaccines.
Rotavirus Vaccine is Now Contraindicated for Infants Diagnosed with Severe Combined Immunodeficiency
June 25, 2010 -- The Centers for Disease Control and Prevention (CDC) published Addition of Severe Combined Immunodeficiency as a Contraindication for Administration of Rotavirus Vaccine in the MMWR (June 11, 2010 / 59(22); 687-688). (Rotavirus Contraindicated)
Update: National Vaccine Recovery Program for H1N1 Influenza Vaccines
Jun 24, 2010 -- The Bureau of Immunization is pleased to provide this updated information on the National Vaccine Recovery Program for H1N1 influenza vaccines.
FDA Revises Recommendations for Rotavirus Vaccines
May 17, 2010 -- The Bureau of Immunization is pleased to bring to your attention this important updated information concerning licensed vaccines against rotavirus, released by the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). (Rotavirus Vaccine)
ACIP Recommendations for Use of Combination Measles-Mumps-Rubella-Varicella Vaccine
May 13, 2010 -- The Bureau of Immunization is pleased to bring to your attention an important report published by the Centers for Disease Control and Prevention (CDC) on May 7, 2010, in the Morbidity and Mortality Weekly Report (MMWR Weekly / Vol. 59 / No. RR3). The report, Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine - Recommendations of the Advisory Committee on Immunization Practices (ACIP) (page 1 - 12), presents the recommendations and use of the combination measles-mumps- rubella-varicella vaccine (MMRV, ProQuad, Merck & Co., Inc.). (MMRV)
Vaccines for Children (VFC) Program Vaccine Availability
May 5, 2010 -- The Bureau of Immunization is pleased to announce the availability of additional vaccines for ordering through the VFC Program.
Effective Wednesday, May 5, 2010, the following vaccines are available for ordering:
- GSK Cervarix®, HPV, NDC 58160-0830-11, 10-pack single dose vial
- GSK Cervarix®, HPV, NDC 58160-0830-46, 5-pack single dose syringe
- Novartis Menveo®, MCV4, NDC 46028-0208-01, 5-pack single dose vial
Effective Monday, May 10, 2010, the following vaccine is available for ordering:
- Merck ProQuad, MMR-V, NDC 00006-4999-00, 10-pack single dose vial
The Advisory Committee on Immunization Practices (ACIP) recommendations are available at www.cdc.gov/vaccines/pubs/ACIP-list.htm. Vaccine Information Statements for these vaccines are available at www.cdc.gov/vaccines/pubs/vis/default.htm.
2010 National Infant Immunization Week (NIIW)
March 23, 2010 -- The Florida Department of Health, Bureau of Immunization is pleased to announce the 2010 National Infant Immunization Week (NIIW) theme: "Love them. Protect them. Immunize them." This year, NIIW will be held during
Nationwide, immunization levels remain high and vaccine-preventable diseases are at an all-time low. In 2008, Florida's immunization coverage level for children aged two was 83.4 percent. The bureau urges providers and parents not to become complacent, since approximately 15 percent of Florida's children are not fully immunized by age two.
Vaccines are among the most successful and cost-effective public health tools available for preventing disease and death. They not only help protect vaccinated individuals, but also help protect entire communities by preventing and reducing the spread of infectious diseases. Immunization is a shared responsibility. Families, healthcare providers, and public health officials must work together to help protect the entire community. Vaccines not only prevent disease, they reduce the costs associated with missed time from work, doctor visits, and hospitalizations.
Healthcare providers play a critical role in educating parents about the importance of immunization and ensuring that infants are fully immunized. Because of the success of vaccines in preventing disease in the U.S., parents are often unaware that their children are at risk for so many serious and life-threatening diseases.
Parents are encouraged to talk to their healthcare provider to ensure that their infant is up-to-date on immunizations. Infants are particularly vulnerable to infectious diseases; that is why it is critical to protect them through immunization. Each day, nearly 12,000 babies are born in the U.S. who will need to be immunized against 14 vaccine-preventable diseases before age two.
Our nation's success in achieving high levels of infant immunization coverage is the result of the work that local health departments, immunization coalitions, individual healthcare professionals, parents and other partners do throughout the year. The bureau encourages you to promote NIIW at the local level and thanks you for your continued commitment to ensure all children have a healthy childhood free from vaccine-preventable diseases. Five NIIW posters are available for download and reproduction on our Publications Website.
Vaccine Information Statement News
April 22, 2010 -- The Bureau of Immunization is pleased to highlight the recent publication of the 13-valent pneumococcal conjugate (PCV13) Vaccine Information Statement (VIS). (PCV13 VIS)
Recommended Vaccine Strains for the 2010-2011 Trivalent Influenza Vaccine
April 16, 2010 -- The Bureau of Immunization would like to bring to your attention the following information presented by the Centers for Disease Control and Prevention regarding the World Health Organization's (WHO) recommendations for the composition of the trivalent influenza vaccine for the 2010-2011 influenza season.
World Meningitis Day 2010
World Meningitis Day is Saturday April 24, 2010, and the Confederation of Meningitis Organisations (CoMO) wants you to Join Hands against Meningitis around the World. They need you to help members raise awareness to prevent this crippling and fatal disease; and help support those who have already been affected.
Meningitis is the inflammation of the lining around the brain and spinal cord. Septicaemia is the blood poisoning form of the disease. The two forms of the disease have different symptoms and can kill in hours. People who recover from meningitis and septicaemia may be left with a range of after effects that dramatically alter their lives.
The CoMO was created out of a need to unite across the world in the fight against Meningitis and Septicaemia. Successful vaccinations have been developed over the past 18 years which have made a huge impact in the reduction of the disease; but there is still a lot of work that needs to be done. There are areas of the world which do not have access to these life saving vaccines, and strains of the disease which we are yet to conquer. Meningitis and septicaemia still kills and disables tens of thousands of people every year throughout the world. These are diseases that affect the most vulnerable — babies and young children.
Join hands against meningitis on World Meningitis Day on April 24, 2010.
Ordering Vaccines for Children Program Vaccines
Important Information Regarding your Publicly-Funded Vaccine Orders
April 14, 2010 -- The Centers for Disease Control and Prevention (CDC) has restructured how it distributes publicly-funded vaccines to providers to improve efficiency and accountability, reduce costs, and enhance the CDC's ability to respond to public health emergencies, including shortages, natural disasters, and disease outbreaks.
Immunization Update: IAC Express, Issue Number 860: "Ask the Experts" Information
April 12, 2010 -- The Bureau of Immunization is pleased to share the following information from the Immunization Action Coalition (IAC) with our immunization partners. The April 7, 2010 IAC Express: Extra Edition includes updated information from "Ask the Experts" regarding Prevnar 13™, the temporary suspension of Rotarix®, and the 2010-2011 seasonal influenza vaccine.
Please pay special attention to the question and answer referencing prophylactic use of acetaminophen prior to or immediately following immunization. "Evidence from a Lancet study would discourage the prophylactic use of acetaminophen prior to or immediately following vaccination. Acetaminophen can be used to treat pain or fever if it should occur following vaccination. In the upcoming 2010 General Recommendations on Immunization, the Centers for Disease Control and Prevention will remove all recommendations for prophylactic use of acetaminophen or other analgesics BEFORE or AT THE TIME OF vaccination. AAP has already removed such recommendations from the Red Book."
Vaccine Information Statement Updates
April 12, 2010 -- The Bureau of Immunization is pleased to highlight recent updates to several vaccine information statements: measles-mumps-rubella-varicella (MMRV), human papillomavirus (HPV), and pneumococcal conjugate vaccine-13 (PCV13). Details can be found at www.cdc.gov/vaccines/pubs/vis/vis-news.htm. Existing stocks may be used up, but be prepared to explain the changes to patients when appropriate.
MMRV: A separate VIS for MMRV is in draft form, and is waiting for a couple issues to be resolved before it goes to clearance. We expect it to be available later this year.
HPV: Updated VISs are here. VISs for Gardasil® and Cervarix®, dated 3/30/2010, were posted on March 31. These are interim VISs, and replace the single HPV VIS dated 2/2/07. Stocks of this older VIS may be used up, although the updated editions are preferred; it may be supplemented verbally or with written materials as appropriate to inform patients of changes (e.g., use of Gardasil® in males). The new VISs are available at www.cdc.gov/vaccines/pubs/vis/default.htm#hpv.
PCV13: Minor changes to the existing PCV VIS will make it applicable for the newly licensed PCV13. These changes are underway, and the new VIS should be ready soon. In the meantime, keep using the current one; contraindications and the adverse event profile for PCV7 also apply to PCV13.
Healthcare providers should periodically access the VIS electronically and print out a supply for routine distribution. If necessary, bureau staff can FAX copies to providers without internet access.
Links to the latest VIS can be found at:
- Centers for Disease Control and Prevention
- Immunization Action Coalition (primary source for translated VIS)
U.S. Court of Federal Claims - Special Masters Ruling on Vaccines and Autism
March 29, 2010 -- The Bureau of Immunization wishes to bring to your attention the following important information concerning vaccine safety, specifically the March 10, 2010 ruling by U.S. Court of Federal Claims Special Masters that thimerosal-containing vaccines do not cause autism.
This topic has been of considerable concern to the scientific community, parents, and public health officials. Herein, we provide links to valid information and articles which will be of use to you in discussing these issues.
Omnibus Autism Proceeding
The Omnibus Autism Proceeding was created by the National Vaccine Injury Compensation Program to handle the large volume of claims that vaccines induce autism. In order to ensure that the over 4,900 cases are dealt with in a timely manner, the U.S. Court of Federal Claims has divided the claims into three theories:
- Theory 1 (conducted in 2007): On February 12, 2009, the Special Masters ruled that the measles-mumps-rubella vaccine (MMR), in combination with thimerosal-containing vaccines (TCVs), do not cause or contribute to autism.
- Theory 2 (heard in 2008): On March 12, 2010, the Special Masters ruled that thimerosal-containing vaccines do not contribute to or cause autism.
- Theory 3: The theory that MMR vaccine alone can cause autism was voluntarily dismissed by the Petitioners' Steering Committee in 2008.
Additional Materials
These rulings and the formal retraction by the Lancet of the controversial Wakefield paper, (The Lancet, Volume 375, Issue 9713, Page 445, 6 February 2010) are now fundamental to us in our efforts to alleviate some fears that parents of unimmunized children still harbor.
IMPORTANT: Wyeth Recalls 4 Lots of Privately Sold Prevnar® Pneumococcal 7-Valent Conjugate Vaccine
March 23, 2010 -- The Bureau of Immunization, as part of our commitment to our partners, brings to your attention the following Centers for Disease Control and Prevention (CDC) information distributed on March 23, 2010, regarding Wyeth's voluntary recall of 4 lots of privately sold Prevnar® Pneumococcal 7-Valent Conjugate Vaccine. (Prevnar® 7 Recall)
IMPORTANT: FDA Recommends Suspension of Rotarix® Vaccine
March 22, 2010 -- The Food and Drug Administration (FDA) recommends that healthcare practitioners temporarily suspend use of the Rotarix® vaccine for rotavirus immunization in the U.S. while the agency learns more about components of an extraneous virus detected in the vaccine. There is no evidence at this time that this finding poses a safety risk. (Suspension of Rotarix)
Summary of School Immunization Requirements for School Year 2010/2011
March 19, 2010 -- There are no changes or new vaccines added to the school immunization requirements for school year 2010/2011. The Immunization Guidelines for Florida Schools, Childcare Facilities and Family Daycare Homes July 2008 are still effective.
Updates to existing grade phase-in for the following immunization requirements:
- Students entering Kindergarten through grade 2 should have documentation of 2 doses of varicella vaccine.
- Students entering grade 3 through grade 9 should have documentation of 1 dose of varicella vaccine.
- Students entering grades 7 and 8 should have documentation of a Tdap dose. Temporary Medical Exemptions for students who have had a Td prior to age 11 are valid for 2 to 5 years.
- Students entering Kindergarten and grade 1 should have documentation of 2 MMRs. (Students in grades 2 through 12 with a valid Florida Certification of Immunization Form DH 680 and 2 measles, 1 mumps and 1 rubella should not be excluded. However, if their records are reviewed they should be advised to update their records or receive a 2nd MMR.
The flyer 2010-2011 School Entry Requirements can be printed and shared with parents and guardians.
Staff providing immunizations should review the Recommended Immunization Schedules for Persons Aged 0 Through 18 Years--- United States, 2010.
One change in the Recommended Immunization Schedule should be noted for those conducting Kindergarten Round-ups or back-to-school clinics: The last dose in the inactivated poliovirus vaccine (IPV) series is now recommended to be administered on or after the fourth birthday and at least 6 months after the previous dose. If a child received all 4 doses prior to their fourth birthday, an additional (fifth) dose should be administered at age 4 through 6 years.
The Florida SHOTS™ has been updated to reflect an additional algorithm for IPV and the Florida Certification of Immunization Form DH 680 will accommodate documentation of a fifth dose to reflect the recommendation.
Please note: This is not a school requirement for the 2010/2011 school year. The Immunization Guidelines for Florida Schools, Childcare Facilities and Family Daycare Homes will be updated to reflect this change for the 2011/2012 school year, which will apply ONLY to kindergarten entry. Do not invalidate existing DH 680s on file at schools or recall children who are already attending school.
ACIP Recommendations for Pneumococcal Conjugate and Meningococcal Vaccines
March 18, 2010 -- The Bureau of Immunization is pleased to bring to your attention two important articles published by the Centers for Disease Control and Prevention (CDC) on March 12, 2010, in the Morbidity and Mortality Weekly Report (MMWR Weekly / Vol. 59 / No. 9). (Pneumococcal Vaccines) (Meningococcal Vaccines)
CDC Health Alert: Travel Notice During Multi-State Mumps Outbreak
March 12, 2010 -- The Bureau of Immunization is pleased to bring the following Health Alert Network (HAN) message to your attention. (Mumps Outbreak)
New Vaccines to Prevent Invasive Pneumococcal and Meningococcal Disease
Prevnar 13™
March 9, 2010 -- Wyeth received Food and Drug Administration (FDA) approval for a 13-valent Pneumococcal Conjugate Vaccine (PCV13) known as Prevnar 13™. (Prevnar 13™)
Menveo®
March 9, 2010 -- Novartis received FDA approval of Menveo® (Meningococcal [Groups A, C, Y, and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine). (Menveo®)
ATTENTION: Sanofi Pasteur Shortens Shelf Life on 50 lots of H1N1 Vaccine
February 8, 2010 -- The Bureau of Immunization, as part of our commitment to our partners, brings to your attention the following Centers for Disease Control and Prevention (CDC) information distributed via the Health Alert Network Tuesday, February 2, 2010, concerning the adjustment of the shelf life of specific lot numbers of Sanofi Pasteur monovalent 2009 (H1N1) influenza vaccine in pre-filled syringes.
Letter from Thomas R. Frieden, MD, MPH,
Director of the Centers for Disease Control and Prevention
February 3, 2010 -- In conjunction with Thomas R. Frieden, MD, MPH, Director of the Centers for Disease Control and Prevention, the Bureau of Immunization adds our support to Dr. Frieden's encouragement to all healthcare providers to make efforts to ensure all children are fully protected against novel H1N1 influenza through administration of both doses of vaccine recommended for children from 6 months through 9 years of age.
IMPORTANT: Non-Safety-Related Voluntary Recall of Sanofi Pasteur Lot Numbers for H1N1 Vaccine in Pre-Filled Syringes
February 2, 2010 -- The Bureau of Immunization is forwarding this Health Alert Network Update titled Non-Safety-Related Voluntary Recall of Unused Doses from Certain Lots of Sanofi Pasteur H1N1 Vaccine in Pre-Filled Syringes.
Interim Immunization Recommendations for Evacuees from Haiti
January 28, 2010 -- The Bureau of Immunization would like to provide the following information in regards to immunizing evacuees from Haiti.
Children and adults arriving without immunization records, should be considered susceptible and be provided the following age-appropriate immunizations: measles-mumps-rubella, polio, tetanus-diphtheria-pertussis, varicella, Haemophilus influenzae type B, pneumococcal conjugate, influenza, meningitis, rotavirus, and hepatitis A and B, in addition to any other vaccinations against vaccine-preventable diseases, as recommended by the Advisory Committee on Immunization Practices (ACIP).
Repatriated citizens from Haiti are citizens of the U.S., and their dependents, who have returned to the U.S. due to the earthquake in Haiti. These citizens may be homeless upon entering Florida. If a child is homeless, as defined in Section 1003.01, Florida Statutes, a temporary exemption may be issued by an authorized school official for a period not to exceed 30 days, to allow adequate time to access healthcare resources for immunization services. These children are required to receive immunizations within the first 30 days of school entry.
Children who meet the following definitions may be granted humanitarian parole status and placed with their adoptive parents or prospective adoptive parents:
- Children who have been legally confirmed as orphans eligible for inter-country adoption by the Government of Haiti and are being adopted by U.S. citizens.
- Children who have been previously identified by an adoption service provider or facilitator as eligible for inter-country adoption and have been matched to U.S. citizen prospective adoptive parents.
These children are required to receive immunizations prior to school entry. A child who has received as many immunizations as are medically indicated at this time, and is in the process of completing necessary immunizations, may attend kindergarten through 12th grade only if he/she presents a Florida Certification of Immunization (DH 680) with appropriate Temporary Medical Exemption (TME).
Under applicable laws, unaccompanied minors entering the country without a parent or legal guardian are subject to special procedures regarding their custody and care. The Department of Homeland Security coordinates with the Department of Health and Human Services (HHS) Office of Refugee Resettlement on these unaccompanied minor cases.
To promote high levels of protection against vaccine-preventable diseases and provide immunizations as quickly as possible to these children, it is recommended that serology testing not be considered an option to determine immunity.
The Centers for Disease Control and Prevention's (CDC) websites, General Recommendations on Immunizations and Recommended Immunization Schedules, provide specific immunization recommendations.
Please note: Immunizations should be documented in the Florida State Health Online Tracking System (Florida SHOTS™). Additionally, documentation of immunizations (Florida Department of Health Immunization Record DH 686) should be provided to the patient or appropriate guardian. This is vital, as the evacuees may relocate, and documentation of these immunizations should be available. Information for ordering the DH 686 is available on the bureau's publications website.
Children attending childcare facilities, family daycare or school (K-12), will need to provide proof of immunizations as documented in Immunization Guidelines for Florida Schools, Childcare Facilities and Family Daycare Homes, with the Florida Certification of Immunization (DH 680), with appropriate TME date for follow-up. The bureau has Baby Shots and School Shots brochures and a 2009/2010 School Requirements flyer in Haitian/Creole. These publications are available on the bureau's publications website.
The Vaccines for Children Program will provide school-required vaccines for children through 18 years of age. Additionally, immunizations are available through the Refugee Health Program for adults from Haiti who meet their program eligibility. To find Refugee Health Program eligibility information and county health department contact information, go to http://www.doh.state.fl.us/disease_ctrl/refugee/index.html or call 850-245-4350.
Recommended Adult Immunization Schedule --- United States, 2010
January 19, 2010 -- The Bureau of Immunization is pleased to announce the release of the Recommended Adult Immunization Schedule --- United States, 2010, by the Centers for Disease Control and Prevention (CDC). The annual recommended immunization schedule for adults in the United States for 2010 is approved by the Advisory Committee on Immunization Practices (ACIP), the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists, and the American College of Physicians. They were published online in the Morbidity and Mortality Weekly Report (MMWR January 15, 2010 / 59(01);1-4), as Recommended Adult Immunization Schedule --- United States, 2010. The changes for 2010 are presented below:
- The human papillomavirus (HPV) footnote (#2) includes language that a bivalent HPV vaccine (HPV2) has been licensed for use in females. Either HPV2 or the quadrivalent human papillomavirus vaccine (HPV4) can be used for vaccination of females 19 through 26 years of age. In addition, language has been added to indicate that the ACIP issued a permissive recommendation for use of HPV4 in males.
- The measles, mumps, rubella (MMR) footnote (#5) has language added to clarify which adults born during or after 1957 do not need 1 or more doses of MMR vaccine for the measles and mumps components, and clarifies which women should receive a dose of MMR vaccine. Also, interval dosing information has been added to indicate when a second dose of MMR vaccine should be administered. Language has been added to highlight recommendations for vaccinating healthcare personnel born before 1957 routinely and during outbreaks.
- The term "seasonal" has been added to the influenza footnote (#6).
- The hepatitis A footnote (#9) has language added to indicate that unvaccinated persons who anticipate close contact with an international adoptee should consider vaccination.
- The hepatitis B footnote (#10) has language added to include schedule information for the 3-dose hepatitis B vaccine.
- The meningococcal vaccine footnote (#11) clarifies which vaccine formulations are preferred for adults 55 years of age and older, and 56 years of age and younger, and which vaccine formulation can be used for revaccination. New examples have been added to demonstrate who should and should not be considered for revaccination.
- The selected conditions for Haemophilus influenzae type b (Hib) footnote (#13) clarifies which high-risk persons may receive 1 dose of Hib vaccine.
The schedule can be accessed in the original document at www.cdc.gov/mmwr/preview/mmwrhtml/mm5901a5.htm, or via the CDC's adult immunization schedule webpage at www.cdc.gov/vaccines/recs/schedules/adult-schedule.htm.
Vaccines for Children Program Provider Handbook Available on CD
Please Note: Under Florida law, email addresses are public records. If you do not want your email address released in response to a public records request, do not send electronic mail to this entity. Instead, contact this office by phone or in writing.
January 19, 2010 -- The Bureau of Immunization is pleased to announce the current Vaccines for Children (VFC) Program Provider Handbook is now available on CD. To request a copy, please contact the VFC Program by email at FloridaVFC@doh.state.fl.us, or by calling 800-483-2543 .
ATTENTION: MedImmune Shortens Shelf Life on 12 lots of H1N1 Intranasal Vaccine
January 11, 2010 -- The Bureau of immunization, as part of our commitment to our partners and our customers, brings to your attention the following Centers for Disease Control and Prevention (CDC) information concerning the adjustment of the shelf life of specific lot numbers of Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal.
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years --- United States, 2010
January 8, 2010 -- The Bureau of Immunization is pleased to announce the release of the Recommended Immunization Schedules for Persons Aged 0 Through 18 Years --- United States, 2010, by the Centers for Disease Control and Prevention (CDC). The annual recommended immunization schedules for children and adolescents in the United States for 2010 were approved by the the Advisory Committee on Immunization Practices (ACIP), American Academy of Pediatrics, and the American Academy of Family Physicians. They were published online in the Morbidity and Mortality Weekly Report (MMWR January 8, 2010 / 58(51&52);1-4), as Recommended Immunization Schedules for Persons Aged 0 Through 18 Years --- United States, 2010. The text of the release is presented below:
The ACIP annually publishes an immunization schedule for persons 0 through 18 years of age that summarizes recommendations for currently licensed vaccines for children 18 years of age and younger and includes recommendations in effect as of December 15, 2009. Changes to the previous schedule include the following:
- The statement concerning use of combination vaccines in the introductory paragraph has been changed to reflect the revised ACIP recommendation on this issue.
- The last dose in the inactivated poliovirus vaccine series is now recommended to be administered on or after the fourth birthday and at least 6 months after the previous dose. In addition, if 4 doses are administered before 4 years of age, an additional (fifth) dose should be administered at 4 through 6 years of age.
- The hepatitis A footnote has been revised to allow vaccination of children older than 23 months of age for whom immunity against hepatitis A is desired.
- Revaccination with meningococcal conjugate vaccine is now recommended for children who remain at increased risk for meningococcal disease after 3 years (if the first dose was administered at 2 through 6 years of age) or after 5 years of age (if the first dose was administered at 7 years of age or older).
- Footnotes for human papillomavirus (HPV) vaccine have been modified to include 1) the availability of and recommendations for bivalent HPV vaccine, and 2) a permissive recommendation for administration of quadrivalent HPV vaccine to males 9 through 18 years of age to reduce the likelihood of acquiring genital warts.
The National Childhood Vaccine Injury Act requires that healthcare providers provide parents or patients with copies of Vaccine Information Statements before administering each dose of the vaccines listed in the schedules. Additional information is available from your county health department and from the CDC at www.cdc.gov/vaccines/pubs/vis/default.htm.
Detailed recommendations for using vaccines are available from the ACIP statements at www.cdc.gov/vaccines/pubs/acip-list.htm, and the 2009 Red Book. Guidance regarding the Vaccine Adverse Event Reporting System form is available at www.vaers.hhs.gov or by telephone, 800-822-7967.
The Schedules can be accessed via the CDC main immunization schedule webpage at www.cdc.gov/vaccines/recs/schedules/child-schedule.htm#printable.
Preteen Vaccine Week 2010
Preteen Vaccine Week promotes the preteen healthcare provider visit and immunizations for 11- and 12-year-olds that can protect them against diseases.
National Influenza Vaccination Week
January 10-16, 2010
The Centers for Disease Control and Prevention (CDC) has announced the week of January 10-16, 2010, as National Influenza Vaccination Week (NIVW). This event highlights the importance of continuing influenza vaccination, as well as fosters greater use of flu vaccine after the holiday season into January and beyond. This year's NIVW (originally scheduled for December 6-10, 2009) is now rescheduled for January 10-16, 2010.
